September 18, 2015
The Japan Pharmaceutical Manufacturers Association’s (JPMA) board issued on September 17 a reprimand to Pfizer Japan over its failure to report adverse drug reactions (ADRs). The company received a business improvement order from the Ministry of Health, Labor and Welfare...read more